Clinicopathologic Features and Genetic Alterations of a Primary Osteosarcoma of the Uterine Corpus

Gang Zheng, Abby Richmond, Chengbao Liu, Alexander Berrebi, Aparna Pallavajjalla, Lisa Haley, Rebecca Stone, Edward McCarthy, Russell S Vang, Deyin Xing

Research output: Contribution to journalArticle

Abstract

Primary osteosarcoma (OS) of the uterus is distinctly rare. We report a case of primary uterine OS with pulmonary metastasis in a 74-yr-old woman. Histopathologic features of the uterine tumor were in keeping with a pure chondroblastic OS composed of neoplastic cells with osteoblastic/chondroblastic differentiation and neoplastic bone formation. Despite treatment with Doxorubicin and Olaratumab and later with palliative radiation therapy, the patient died 7 mo after hysterectomy due to multiple distant metastases. A targeted next-generation sequencing assay based on a 637-gene panel was performed to analyze genetic alterations in this highly aggressive tumor, but no somatic mutations that are amenable to targeted therapy were detected. Rather, a 51-nucleotide deletion mutation including partial exon 2 of mediator complex subunit 12 (MED12), a gene commonly mutated in leiomyoma, breast fibroadenoma and phyllodes tumor, was identified. Given the MED12 mutation in this uterine OS, we propose possible mechanisms that account for the origin and development of this tumor.

Original languageEnglish (US)
Pages (from-to)414-419
Number of pages6
JournalInternational Journal of Gynecological Pathology
Volume38
Issue number5
DOIs
StatePublished - Sep 1 2019

Fingerprint

Osteosarcoma
Mediator Complex
Phyllodes Tumor
Neoplasm Metastasis
Fibroadenoma
Neoplasms
Mutation
Sequence Deletion
Leiomyoma
Hysterectomy
Palliative Care
Osteogenesis
Doxorubicin
Genes
Uterus
Exons
Radiotherapy
Nucleotides
Breast Neoplasms
Lung

Keywords

  • MED12
  • Mutation
  • Osteosarcoma
  • Uterus

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Obstetrics and Gynecology

Cite this

Clinicopathologic Features and Genetic Alterations of a Primary Osteosarcoma of the Uterine Corpus. / Zheng, Gang; Richmond, Abby; Liu, Chengbao; Berrebi, Alexander; Pallavajjalla, Aparna; Haley, Lisa; Stone, Rebecca; McCarthy, Edward; Vang, Russell S; Xing, Deyin.

In: International Journal of Gynecological Pathology, Vol. 38, No. 5, 01.09.2019, p. 414-419.

Research output: Contribution to journalArticle

@article{35e100a44ffa409d9f5ae7d02c02e417,
title = "Clinicopathologic Features and Genetic Alterations of a Primary Osteosarcoma of the Uterine Corpus",
abstract = "Primary osteosarcoma (OS) of the uterus is distinctly rare. We report a case of primary uterine OS with pulmonary metastasis in a 74-yr-old woman. Histopathologic features of the uterine tumor were in keeping with a pure chondroblastic OS composed of neoplastic cells with osteoblastic/chondroblastic differentiation and neoplastic bone formation. Despite treatment with Doxorubicin and Olaratumab and later with palliative radiation therapy, the patient died 7 mo after hysterectomy due to multiple distant metastases. A targeted next-generation sequencing assay based on a 637-gene panel was performed to analyze genetic alterations in this highly aggressive tumor, but no somatic mutations that are amenable to targeted therapy were detected. Rather, a 51-nucleotide deletion mutation including partial exon 2 of mediator complex subunit 12 (MED12), a gene commonly mutated in leiomyoma, breast fibroadenoma and phyllodes tumor, was identified. Given the MED12 mutation in this uterine OS, we propose possible mechanisms that account for the origin and development of this tumor.",
keywords = "MED12, Mutation, Osteosarcoma, Uterus",
author = "Gang Zheng and Abby Richmond and Chengbao Liu and Alexander Berrebi and Aparna Pallavajjalla and Lisa Haley and Rebecca Stone and Edward McCarthy and Vang, {Russell S} and Deyin Xing",
year = "2019",
month = "9",
day = "1",
doi = "10.1097/PGP.0000000000000511",
language = "English (US)",
volume = "38",
pages = "414--419",
journal = "International Journal of Gynecological Pathology",
issn = "0277-1691",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Clinicopathologic Features and Genetic Alterations of a Primary Osteosarcoma of the Uterine Corpus

AU - Zheng, Gang

AU - Richmond, Abby

AU - Liu, Chengbao

AU - Berrebi, Alexander

AU - Pallavajjalla, Aparna

AU - Haley, Lisa

AU - Stone, Rebecca

AU - McCarthy, Edward

AU - Vang, Russell S

AU - Xing, Deyin

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Primary osteosarcoma (OS) of the uterus is distinctly rare. We report a case of primary uterine OS with pulmonary metastasis in a 74-yr-old woman. Histopathologic features of the uterine tumor were in keeping with a pure chondroblastic OS composed of neoplastic cells with osteoblastic/chondroblastic differentiation and neoplastic bone formation. Despite treatment with Doxorubicin and Olaratumab and later with palliative radiation therapy, the patient died 7 mo after hysterectomy due to multiple distant metastases. A targeted next-generation sequencing assay based on a 637-gene panel was performed to analyze genetic alterations in this highly aggressive tumor, but no somatic mutations that are amenable to targeted therapy were detected. Rather, a 51-nucleotide deletion mutation including partial exon 2 of mediator complex subunit 12 (MED12), a gene commonly mutated in leiomyoma, breast fibroadenoma and phyllodes tumor, was identified. Given the MED12 mutation in this uterine OS, we propose possible mechanisms that account for the origin and development of this tumor.

AB - Primary osteosarcoma (OS) of the uterus is distinctly rare. We report a case of primary uterine OS with pulmonary metastasis in a 74-yr-old woman. Histopathologic features of the uterine tumor were in keeping with a pure chondroblastic OS composed of neoplastic cells with osteoblastic/chondroblastic differentiation and neoplastic bone formation. Despite treatment with Doxorubicin and Olaratumab and later with palliative radiation therapy, the patient died 7 mo after hysterectomy due to multiple distant metastases. A targeted next-generation sequencing assay based on a 637-gene panel was performed to analyze genetic alterations in this highly aggressive tumor, but no somatic mutations that are amenable to targeted therapy were detected. Rather, a 51-nucleotide deletion mutation including partial exon 2 of mediator complex subunit 12 (MED12), a gene commonly mutated in leiomyoma, breast fibroadenoma and phyllodes tumor, was identified. Given the MED12 mutation in this uterine OS, we propose possible mechanisms that account for the origin and development of this tumor.

KW - MED12

KW - Mutation

KW - Osteosarcoma

KW - Uterus

UR - http://www.scopus.com/inward/record.url?scp=85071179231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071179231&partnerID=8YFLogxK

U2 - 10.1097/PGP.0000000000000511

DO - 10.1097/PGP.0000000000000511

M3 - Article

VL - 38

SP - 414

EP - 419

JO - International Journal of Gynecological Pathology

JF - International Journal of Gynecological Pathology

SN - 0277-1691

IS - 5

ER -